A comparison of plasma protein changes induced by danazol, pregnancy, and estrogens
Other
OA: closed
CC0
⤵ 37 in-corpus citations
AI-generated summary
Danazol treatment and pregnancy induced distinct but overlapping changes in plasma proteins, suggesting hepatocyte steroid receptor interactions influence protein synthesis differentially.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Analysis of 25 plasma proteins was performed on blood drawn from 7 females before and during treatment with danazol. This steroid was found to induce a pattern of plasma protein changes similar to but not identical with that of other 17 alpha-alkylated anabolic steroids. For comparison, the same 25 plasma proteins were analyzed in blood from pregnant women in their third trimester, when the estrogen influence on plasma protein synthesis is most pronounced. Five major types of response were found. 1) Albumin and orosomucoid were not influenced by danazol or, after correction for volume expansion, by pregnancy. 2) Prealbumin, C1-esterase inhibitor, and haptoglobins increased substantially during danazol treatment but were not significantly influenced by pregnancy. 3) Transferrin, antithrombin III, prothrombin, and plasminogen showed marked increases after administration of danazol and during pregnancy. 4) Transcortin, ceruloplasmin, and alpha 1-antitrypsin doubled in pregnancy but were not influenced by danazol. 5) The concentrations of T4-binding globulin, pregnancy zone protein, and sex hormone-binding globulin more than doubled in pregnancy, and all three decreased to one third or less on administration of danazol. The plasma estradiol content fell correspondingly. The different types of plasma protein response found in these two groups of patients fit the hypothesis that hepatocytes contain steroid receptors capable of reacting with estrogens and/or other steroids such as danazol and, thus, influence the biosynthetic rate of many but not all plasma proteins according to a specific pattern. The synthesis of some of the estrogen-sensitive proteins is depressed after intake of danazol, which suggests that there is a competition for the receptors in the hepatocytes as there is for other estrogen target tissues.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (21)
- Danazol and thyroid-function tests via openalex
- Endocrine effects of danazol in menstruating women. via openalex
- Pharmacology of danazol via openalex
- doi:10.1016/s0039-128x(68)80009-1 via openalex
- doi:10.1210/jcem-32-4-547 via openalex
- doi:10.1016/0005-2787(76)90361-0 via openalex
- doi:10.1016/0010-7824(71)90060-6 via openalex
- doi:10.1016/0022-4731(79)90062-1 via openalex
- doi:10.1016/0092-8674(75)90167-1 via openalex
- doi:10.1210/endo-102-2-433 via openalex
- doi:10.1530/acta.0.0880003-b via openalex
- doi:10.1042/bj0980621 via openalex
- doi:10.1210/jcem-33-3-388 via openalex
- doi:10.1210/jcem-36-4-706 via openalex
- doi:10.3109/00365517209102755 via openalex
- doi:10.1126/science.175442 via openalex
- doi:10.1210/jcem-27-8-1081 via openalex
- doi:10.1056/nejm197612232952602 via openalex
- doi:10.3109/00365516809076990 via openalex
- doi:10.3109/00365516809077003 via openalex
- doi:10.1016/0002-9378(70)90301-7 via openalex
Cited by (38)
- Danazol therapy in familial antithrombin III deficiency 2008
- Danazol therapy in factor X deficiency 2001
- Altered sensitivity to anti-endometriosis medicines in an adenomyosis patient with thyroid dysfunction 2000
- Efficacy of danazol in a patient with congenital protein-S deficiency: paradoxical evidence for decreased platelet activation with increased thrombin generation 1997
- Plasma protein changes induced by two orally administered androgen derivatives 1996
- Acquired hypoprothrombinemia: effects of danazol treatment 1996
- Stanozolol and danazol, unlike natural androgens, interact with the low affinity glucocorticoid-binding sites from male rat liver microsomes 1994
- Medical management of endometriosis 1993
- Tissue and endocrine responses to gestrinone and danazol in the treatment of endometriosis 1993
- Lipoprotein Lp(a) levels are reduced by danazol, an anabolic steroid 1992
- Inhibitory and stimulatory actions of danazol in rat ovarian and uterine tissues 1992
- The use of danazol as a treatment of endometriosis 1991
- Comparison of the pharmacology of nafarelin and danazol 1990
- The medical treatment of endometriosis with danazol and gestrinone: A study of their clinical, endocrine and in vitro effects. 1990
- Placebo-controlled comparison of hormonal and biochemical effects of danazol and high-dose medroxyprogesterone acetate 1990
- A Study on the Antithrombotic Effect of Danazol 1990
- Glucose tolerance and insulin resistance after danazol treatment 1989
- Danazol concentrations in human ovarian follicular fluid and their relationship to simultaneous serum concentrations 1988
- Cyclical mastopathy: a critical review of therapy 1988
- Danazol fails to increase factor VIII or IX levels in a double-blind crossover study of patients with haemophilia A and B 1986
- A comparison of the effects of danazol and gestrinone on testosterone binding to sex hormone binding globulin in vitro and in vivo 1986
- Dosage-related effects of danazol on sex hormone binding globulin and free and total androgen levels 1986
- Biochemical basis for the antagonism between aminoglutethimide and danazol in the endocrine treatment of breast cancer 1986
- Serum estradiol and danazol. I. Endometriosis response, side effects, administration interval, concurrent spironolactone and dexamethasone 1985
- Danazol and hemophilia 1985
- Profound alterations of the lipoprotein metabolism during danazol treatment in premenopausal women 1984
- Danazol treatment of severely symptomatic fibrocystic breast disease and long-term follow-up--the Hjørring project 1984
- Changes in the SHBG concentration during danazol treatment 1984
- Effect of danazol on thyroid function in postmenopausal women 1984
- Serum estradiol and danazol. I. Endometriosis response, side effects, administration interval, concurrent spironolactone and dexamethasone 1984
- Androgenic, anabolic, estrogenic and antiestrogenic effects of desogestrel and lynestrenol: effects on serum proteins and vaginal cytology 1984
- Endocrine effects of danazol in the treatment of endometriosis 1984
- Peripheral androgen levels in danazol-treated premenopausal women 1983
- Free testosterone levels during danazol therapy 1983
- Danazol 1982
- The effects of danazol 1982
- Danazol and gestagen displacement of testosterone and influence on sex-hormone-binding globulin capacity 1982
- Cholesterol, high density lipoprotein and danazol 1981
Source provenance
- europepmc
- last seen: 2026-10-18T09:30:06.152893+00:00
- openalex
- last seen: 2026-05-10T10:26:17.946222+00:00
- pubmed
- last seen: 2026-10-08T21:57:33.264577+00:00
- unpaywall
- last seen: 2026-10-24T06:30:43.844863+00:00
License: CC0
· commercial use OK